Henderson; Jaclyn Louise

Patent Applications and Registrations

Patent applications and USPTO patent grants for Henderson; Jaclyn Louise.The latest application filed is for "novel imidazo[4,5-c]quinoline derivatives as lrrk2 inhibitors".

Company Profile

10.17.21

Henderson; Jaclyn Louise - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands Grant 11,390,623 - Chappie , et al. July 19, 2	2022-07-19
Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors Grant 11,312,713 - Brodney , et al. April 26, 2	2022-04-26
Novel Imidazo[4,5-c]quinoline Derivatives As Lrrk2 Inhibitors App 20210355117 - BRODNEY; Michael Aaron ; et al.	2021-11-18
Cyclic substituted imidazo[4,5-c]quinoline derivatives Grant 11,161,844 - Chappie , et al. November 2, 2	2021-11-02
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20210300899 - Brodney; Michael Aaron ; et al.	2021-09-30
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 11,014,909 - Brodney , et al. May 25, 2	2021-05-25
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20200283407 - Brodney; Michael Aaron ; et al.	2020-09-10
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 10,696,658 - Brodney , et al. June 30, 2	2020-06-30
6,7,8,9-tetrahydro-5h-pyrido[2,3-d]azepine Dopamine D3 Ligands App 20200157098 - Chappie; Thomas Allen ; et al.	2020-05-21
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands Grant 10,590,128 - Chappie , et al.	2020-03-17
Cyclic Substituted Imidazo[4,5-c]quinoline Derivatives App 20200039977 - Chappie; Thomas Allen ; et al.	2020-02-06
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20190367485 - Brodney; Michael Aaron ; et al.	2019-12-05
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 10,421,744 - Brodney , et al. Sept	2019-09-24
6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-d]AZEPINE DOPAMINE D3 LIGANDS App 20190047997 - Chappie; Thomas Allen ; et al.	2019-02-14
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20190002439 - BRODNEY; MICHAEL AARON ; et al.	2019-01-03
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 10,093,655 - Brodney , et al. October 9, 2	2018-10-09
Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors Grant 10,039,753 - Coffman , et al. August 7, 2	2018-08-07
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20180200253 - COE; JOTHAM WADSWORTH ; et al.	2018-07-19
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20180037571 - BRODNEY; MICHAEL AARON ; et al.	2018-02-08
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,822,097 - Brodney , et al. November 21, 2	2017-11-21
3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors Grant 9,695,171 - Galatsis , et al. July 4, 2	2017-07-04
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20170165270 - COE; JOTHAM WADSWORTH ; et al.	2017-06-15
Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors Grant 9,642,855 - Galatsis , et al. May 9, 2	2017-05-09
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,617,275 - Coe , et al. April 11, 2	2017-04-11
Novel Imidazo[4,5-c]Quinoline And Imidazo[4,5-c][1,5]Naphthyridine Derivatives As LRRK2 Inhibitors App 20170073343 - Galatsis; Paul ; et al.	2017-03-16
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20170057947 - BRODNEY; MICHAEL AARON ; et al.	2017-03-02
NOVEL 3,4-DISUBSTITUTED-1H-PYRROLO[2,3-b]PYRIDINES AND 4,5-DISUBSTITUTED-7H-PYRROLO[2,3-c]PYRIDAZINES AS LRRK2 INHIBITORS App 20170002000 - Galatsis; Paul ; et al.	2017-01-05
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,527,831 - Brodney , et al. December 27, 2	2016-12-27
Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d]Pyrimidines As LRRK2 Inhibitors App 20150366874 - Galatsis; Paul ; et al.	2015-12-24
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20150344490 - COE; JOTHAM WADSWORTH ; et al.	2015-12-03
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20150291625 - COE; JOTHAM WADSWORTH ; et al.	2015-10-15
4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitors Grant 9,156,845 - Galatsis , et al. October 13, 2	2015-10-13
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,139,561 - Brodney , et al. September 22, 2	2015-09-22
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,107,923 - Brodney , et al. August 18, 2	2015-08-18
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150196561 - BRODNEY; MICHAEL AARON ; et al.	2015-07-16
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150175573 - BRODNEY; MICHAEL AARON ; et al.	2015-06-25
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150005313 - BRODNEY; MICHAEL AARON ; et al.	2015-01-01
Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d] Pyrimidines As LRRK2 Inhibitors App 20140005183 - Galatsis; Paul ; et al.	2014-01-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.